Literature DB >> 33392070

Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer.

Shiyong Lin1, Qianwen Liu1, Jing Wen2, Kunhao Bai1, Yandong Guo2, Jing Wang2.   

Abstract

BACKGROUND: Inflammation often induces regeneration to repair the tissue damage. However, chronic inflammation can transform temporary hyperplasia into a fertile ground for tumorigenesis. Here, we demonstrate that the miR-124 acts as a safeguard to inhibit the pro-inflammatory production and reparative regeneration.
METHODS: The expression levels of miR-124 and IL-17, IFN-γ were detected by qRT-PCR. TH17 or TH1 cells were detected by flow cytometer, respectively. The binding of STAT3 to the promoter region of IL-17 gene was analyzed by Chip assay. miR-124 binding to the 3'UTR of STAT3 gene was detected by reported plasmid construction and luciferase assay. Furthermore, DSS-induced colitis mice model and T cell transfer model were used to confirm the function of miR-124 in vivo. The related gene expression was analyzed by ELISA and western blot experiments.
RESULTS: The results indicated that miR-124 decrease promotes colon tumorigenesis after Citrobacter rodentium infection and AOM/DSS induced colon cancer murine model. In molecular mechanism, miR-124 targets STAT3 to inhibit TH17 cell polarization and keep TH17 polarization in colonic microenvironment.
CONCLUSIONS: Our study strengthened the important role of miR-124 in the regulation of adaptive immune responses and blocking the development of colitis-related cancer.
Copyright © 2020 Lin, Liu, Wen, Bai, Guo and Wang.

Entities:  

Keywords:  STAT3; TH17 cell; colitis; colitis-related cancer; miR-124

Year:  2020        PMID: 33392070      PMCID: PMC7773897          DOI: 10.3389/fonc.2020.570128

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  27 in total

1.  MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.

Authors:  Kohei Taniguchi; Nobuhiko Sugito; Minami Kumazaki; Haruka Shinohara; Nami Yamada; Yoshihito Nakagawa; Yuko Ito; Yoshinori Otsuki; Bunji Uno; Kazuhisa Uchiyama; Yukihiro Akao
Journal:  Cancer Lett       Date:  2015-03-24       Impact factor: 8.679

2.  Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria.

Authors:  Christine M Dejea; Payam Fathi; John M Craig; Annemarie Boleij; Rahwa Taddese; Abby L Geis; Xinqun Wu; Christina E DeStefano Shields; Elizabeth M Hechenbleikner; David L Huso; Robert A Anders; Francis M Giardiello; Elizabeth C Wick; Hao Wang; Shaoguang Wu; Drew M Pardoll; Franck Housseau; Cynthia L Sears
Journal:  Science       Date:  2018-02-01       Impact factor: 47.728

3.  Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.

Authors:  Elias Stagakis; George Bertsias; Panayotis Verginis; Magdalene Nakou; Maria Hatziapostolou; Heraklis Kritikos; Dimitrios Iliopoulos; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2011-05-20       Impact factor: 19.103

4.  IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.

Authors:  Jonas Mudter; Jingling Yu; Christel Zufferey; Anne Brüstle; Stefan Wirtz; Benno Weigmann; Arthur Hoffman; Mirjam Schenk; Peter R Galle; Hans A Lehr; Christoph Mueller; Michael Lohoff; Markus F Neurath
Journal:  Inflamm Bowel Dis       Date:  2011-02-08       Impact factor: 5.325

5.  Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation.

Authors:  Subhash K Tripathi; Zhi Chen; Antti Larjo; Kartiek Kanduri; Kari Nousiainen; Tarmo Äijo; Isis Ricaño-Ponce; Barbara Hrdlickova; Soile Tuomela; Essi Laajala; Verna Salo; Vinod Kumar; Cisca Wijmenga; Harri Lähdesmäki; Riitta Lahesmaa
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

Review 6.  MicroRNAs and Inflammation in Colorectal Cancer.

Authors:  Claire Josse; Vincent Bours
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

7.  MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.

Authors:  Yaling Liu; Yu Zhou; Xiao Feng; Ping An; Xiaojing Quan; Hao Wang; Shicai Ye; Caiyuan Yu; Yanting He; Hesheng Luo
Journal:  Int J Oncol       Date:  2013-11-05       Impact factor: 5.650

8.  IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer.

Authors:  Xiaowei Chen; Michael J Churchill; Karan K Nagar; Yagnesh H Tailor; Timothy Chu; Brittany S Rush; Zhengyu Jiang; Edwin B C Wang; Bernhard W Renz; Hongshan Wang; Ming Chiu Fung; Daniel L Worthley; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncotarget       Date:  2015-10-20

9.  JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation.

Authors:  Tiffany M Carr; Joshua D Wheaton; Geoffrey M Houtz; Maria Ciofani
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

10.  The miR-124-p63 feedback loop modulates colorectal cancer growth.

Authors:  Kuijie Liu; Hongliang Yao; Sanlin Lei; Li Xiong; Haizhi Qi; Ke Qian; Jiqiang Liu; Peng Wang; Hua Zhao
Journal:  Oncotarget       Date:  2017-04-25
View more
  2 in total

Review 1.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

2.  Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma.

Authors:  Zhengrong Zou; Yongjie Chai; Qi Li; Xuan Lin; Qingfang He; Qiusheng Xiong
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.